Skip to main content

Advertisement

Table 1 Patient isolate data

From: Susceptibility of human Plasmodium knowlesi infections to anti-malarials

Isolate Species % starting parasitaemia % schizont at start of assay Duration of in vitro development (h) % schizont at end of assay
P0002 Pk 0.4 15 12 80
P0003 Pk 0.6 10 12 86
P0006 Pk 0.8 33 17 53
P0009 Pk 7.0a 17 15 94
P0010 Pk 0.8 6 12 63
P0011 Pk 1.3 8 14 54
P0007 Pf 2.0a 0 31 50
P0001 Pv 0.5 20 18 58
P0013 Pv 0.5 30 29 60
  1. aAbove Mark III assay cut-off (for examination of P. falciparum mono-infections), assuming a parasitaemia of 1.6% equates to approximately 80,000 parasites per μl of blood, and was used undiluted. Note that in both cases good schizont development was observed.
  2. For each isolate, the species, parasitaemia and change in development over time are presented.